North American Vaccine Inc – ‘8-K’ for 3/16/00

On:  Friday, 3/24/00   ·   For:  3/16/00   ·   Accession #:  898432-0-256   ·   File #:  1-10451

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         3     10K 
 2: EX-99.1     Miscellaneous Exhibit                                  1      7K 
 3: EX-99.2     Miscellaneous Exhibit                                  1      7K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 -------------------------

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 -------------------------

Date of Report (Date of earliest event reported): March 16, 2000
                                                  ----------------

NORTH AMERICAN VACCINE, INC.
 ---------------------------------------------
(Exact name of registrant as specified in its charter)

  Canada                     1-10451                    98-0121241
----------------------------  ------------------       -------------------- 
(State or other jurisdiction  (Commission File No.)      (IRS Employer      
 of incorporation)                                       Identification No.)

10150 Old Columbia Road Columbia, Maryland              21046 
--------------------------------------------------------------------------- 
  (Address of principal executive offices)              (Zip Code)

Registrant's telephone number, including area code: (410) 309-7100
                                                    --------------

--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)

                               Exhibit Index is on page 2.

8-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.   OTHER EVENTS.                                                         

      On March 16, 2000, North American Vaccine, Inc. (the "Company"),  issued a
press release  regarding the status of its acquisition by Baxter  International,
Inc. ("Baxter").  The March 16 press release is attached hereto as Exhibit 99.1.
On March 17, 2000, the Company issued a  supplemental  press release  clarifying
certain  details from the March 16 press release.  The March 17 press release is
attached hereto as Exhibit 99.2.                                                

ITEM 7.   FINANCIAL STATEMENTS AND EXHIBITS.                                    

99.1.  Press release, dated March 16, 2000.                                     

99.2.  Press release, dated March 17, 2000.                                     

2 

8-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.                                           

NORTH AMERICAN VACCINE, INC.

By: /s/ Lawrence J. Hineline
        ----------------------------
        Lawrence J. Hineline
           Vice President, Finance

Dated:    March 24, 2000                                                        

3 

Dates Referenced Herein

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on:		3/24/00		3					None on these Dates
		3/17/00		2
For Period End:		3/16/00		1		2
									List all Filings